Public deliverables

 

This list details the deliverable documents foreseen for the project and provides the link to them when their dissemination is open to the public.


D6.1.- Public Website:
Public website up and running to centralize BE-SAFE products

D2.1.- Guidelines to reduce BSH: Trustworthy guidelines to reduce BSHs published on MAGICapp website and BE-SAFE portal

D1.1.- Clinical pathways and healthcare system: Current key clinical pathways (or care trajectories) in relation to BSH reduction identified and described in the six participating European countries

D1.2.- Barriers and enablers to reduce BSHs: Report of the survey, presenting the barriers and enablers to discontinuing BSHs among patients, informal carers and health care professionals in the six European countries

D3.1.- Therapeutic protocol for BSH discontinuation

D3.2.- Educational materials for physicians and patients: Full set of educational materials for physicians and patient card that will be used in the trial, in the local language of each participating country.

D6.3.- Information material for the general public. Comprehensive set of information material related to overuse of BSH  

D6.5.- BE-SAFE podcasts online: Collection of Podcasts files tackling key topics related BSH addressed health professionals and general public

D5.1.- Case study results and updated country-specific logical models: Description of the results of the mixed-method process evaluation performed in the six countries and presentation of the updated logical models for each country

D5.2.- Cross-country logical model: Cross-country BE-SAFE program logical model with data on differences and similarities between countries

D1.3.- PREM to reduce harmful medications: Description of the method for development, the results and of the final version of the PREM questionnaire, in the six languages

D2.3.- Updated trustworthy guideline with recommendations for clinical practice and for implementation strategies: Publication of updated trustworthy guideline with recommendations for clinical practice and for implementation strategies, based on BE-SAFE results.

D3.3.- Definitive version of the materials and procedures for patients and physicians: Definitive full set of educational materials for physicians and patient, adapted based on the results of WP4 and WP5.

D5.3.- Adapted clinical pathways: Description of clinical pathways (or care trajectories) in relation to BSH reduction in the six participating European countries, adapted based on results from the case study analyses

D6.6.- Knowledge translation plan: Public knowledge translation plan and strategy plan for sustainable implementation